A method for the treatment of congestive heart failure in humans using pirbuterol or pharmaceutically acceptable acid addition salts thereof.
A method of treatment is provided for reducing or eliminating psychomotor addiction in mammalian subjects, employing as an active agent 3-phenoxypyridine or a pharmaceutically acceptable acid-addition salt thereof.